search
Back to results

Increasing Access to Fertility Preservation for Women With Breast Cancer (EVAPREF)

Primary Purpose

Breast Cancer

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Informational brochure for patients and brief training for oncologists
Sponsored by
University Paul Sabatier of Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Breast Cancer focused on measuring Breast cancer, Fertility preservation, Information, Practitioner training, Social inequalities in health, Participatory approach, Combined intervention

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy. People who are able to read the study information poster and the fertility preservation information brochure in French, either alone or with help from a caregiver or relative or an interpreter. People with intellectual disability will be included as long as they are able able to read the study information poster and the fertility preservation information brochure in French alone or with help from a caregiver or relative or an interpreter.. Exclusion Criteria: People whose mental health status precludes participation in the study, as determined by the clinical team.

Sites / Locations

  • CHU NantesRecruiting
  • Institut Claudius Regaud (IUCT-O)Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Usual care

Intervention: informational brochure for patients and brief training for oncologists

Arm Description

Usual care information to fertility preservation counseling

The intervention is based on information provided to different target populations, using a variety of media, including brochures and videos.

Outcomes

Primary Outcome Measures

Rate of recourse to fertility preservation consultation before and after using the combined intervention
This information will be collected by each regional screening coordination center of the two participating regions from the medical records of patients

Secondary Outcome Measures

Full Information

First Posted
June 26, 2023
Last Updated
September 1, 2023
Sponsor
University Paul Sabatier of Toulouse
Collaborators
National Cancer Institute, France, Institut Claudius Regaud, Réseau Onco-Occitanie, Réseau ONCOPL
search

1. Study Identification

Unique Protocol Identification Number
NCT05989776
Brief Title
Increasing Access to Fertility Preservation for Women With Breast Cancer
Acronym
EVAPREF
Official Title
Assessment and Improvement of Regional Information and Coordination Tools to Promote Access to Fertility Preservation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Paul Sabatier of Toulouse
Collaborators
National Cancer Institute, France, Institut Claudius Regaud, Réseau Onco-Occitanie, Réseau ONCOPL

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The EVAPREF project aims to increase access to fertility preservation by developing an approach to improve and evaluate existing information and coordination tools developed by the Pays-de-la-Loire and Occitanie Regional Cancer networks. First, the investigators will use a qualitative, iterative, user-centered and participatory approach to improve the current tools and create training content for the physicians who will use these tools. Second, the investigators will conduct a randomized stepped wedge trial of women under 40 newly treated with chemotherapy for breast cancer. The investigators will evaluate the rate of fertility preservation consultation before and after implementation of the improved tools, over a 30-month period from mid-2023 to the end of 2025. Finally, in a third step, the investigators will study their approach (context-sensitive implementation analysis) and provide key elements for its transferability to other contexts and in particular to other Regional Cancer networks in France.
Detailed Description
Background: With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, such as gonadotoxicity. Fertility preservation is becoming increasingly important in cancer management. International recommendations agree on the need to inform patients prior to treatments about the risk of fertility impairment and refer them to specialized centers to discuss fertility preservation. However, the literature reveals suboptimal access to fertility preservation on an international scale, and particularly in France, making information for patients and oncologists a potential lever for action. The overall goal is to improve access to fertility preservation and related consultations for women with breast cancer through the development and evaluation of a combined intervention targeting the diffusion of information for these patients and brief training for oncologists. Methods: First, the investigators will use a qualitative, iterative, user-centered and participatory approach to improve existing information tools and create training content for oncologists (Aim 1). Second, the investigators will conduct a randomized stepped-wedge trial evaluating rate of fertility preservation consultation over a 30-month period (Aim 2). The investigators will include 750 women aged 18 to 40 newly treated with chemotherapy for breast cancer at one of 6 participating centers. The primary outcome will be rate of fertility preservation consultation before and after using the combined intervention (informational brochure for patients and brief training for oncologists) and will be analyzed using linear regression models.Third, the investigators will analyze their approach (context-sensitive implementation analysis) and provide key elements for transferability to other contexts in France (Aim 3). Discussion: After transitioning to the combined intervention, the investigators will expect to observe an increase in access to fertility preservation consultation. Particular attention will be paid to the effect of this intervention on socially disadvantaged women, who are known to be at greater risk of inappropriate treatment. In addition, the user-centric design principles and participatory approaches used to optimize the acceptability, usability and feasibility of the combined intervention will likely enhance its impact, diffusion and sustainability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Breast cancer, Fertility preservation, Information, Practitioner training, Social inequalities in health, Participatory approach, Combined intervention

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators will conduct a randomized stepped-wedge trial multi-site evaluating access to fertility preservation counseling over a 30-month period.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
750 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Usual care information to fertility preservation counseling
Arm Title
Intervention: informational brochure for patients and brief training for oncologists
Arm Type
Active Comparator
Arm Description
The intervention is based on information provided to different target populations, using a variety of media, including brochures and videos.
Intervention Type
Behavioral
Intervention Name(s)
Informational brochure for patients and brief training for oncologists
Intervention Description
For this randomized, stepped wedge trial, the investigators planned a mixed intervention that targets both health professionals and patients. This intervention will be carried out in its entirety thanks to the working groups made up of health professionals and expert patients that took place before the randomized trial. The intervention for health professionals consists of awareness training. They will be trained (or made aware) at different times, defined by randomization. The intervention for patients consists of a pictorial information brochure and tabular patient decision aid given by trained health professionals.
Primary Outcome Measure Information:
Title
Rate of recourse to fertility preservation consultation before and after using the combined intervention
Description
This information will be collected by each regional screening coordination center of the two participating regions from the medical records of patients
Time Frame
up to 18 mont post enrollment

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients over 18 and under 40 years of age treated for newly diagnosed breast cancer and receiving chemotherapy. People who are able to read the study information poster and the fertility preservation information brochure in French, either alone or with help from a caregiver or relative or an interpreter. People with intellectual disability will be included as long as they are able able to read the study information poster and the fertility preservation information brochure in French alone or with help from a caregiver or relative or an interpreter.. Exclusion Criteria: People whose mental health status precludes participation in the study, as determined by the clinical team.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marie-Anne Durand, PhD
Phone
0033648038356
Email
marie-anne.durand@univ-tlse3.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Sébastien Lamy, PhD
Phone
0033684449479
Email
lamy.sebastien@iuct-oncopole.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie-Anne Durand, PhD
Organizational Affiliation
Université Toulouse III Paul Sabatier
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Nantes
City
Nantes
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Delphine Lauzeille
Email
delphine.lauzeille@chu-nantes.fr
Facility Name
Institut Claudius Regaud (IUCT-O)
City
Toulouse
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Charlotte Morel
Email
morel@onco-occitanie.frcopole.fr

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Increasing Access to Fertility Preservation for Women With Breast Cancer

We'll reach out to this number within 24 hrs